Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.
Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, ...
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its ...
Combriax demonstrates strong immunogenicity across age groups, exceeding comparator vaccines for multiple influenza strains ...